During follow-up, providers evaluate pain scores, neurological function, quality of life, and overall treatment tolerance
PT-141 is a synthetic peptide that activates specific receptors in the brain responsible for sexual arousal
What the Study Does Not Show This is a cross-sectional survey, not a clinical outcomes study, and its limits should be stated plainly rather than buried
If a patient is not tolerating the medication well, not seeing expected progress, or struggling with energy and protein intake, the plan can be refined rather than abandoned
Recent research shows that for people with long-term psychiatric illnesses, such as major depressive disorder, bipolar disorder, or schizophrenia, there are structural changes that take place in the brain.[ref] For me, the mental image is that neurotransmitters are acting like software, and altering the software code can alter mood